Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue

Analytical and Bioanalytical Chemistry

Volumn 395, Issue 8, 2009, Pages 2443-2456

  Röwer, Claudia ^a   Vissers, Johannes P C ^b   Koy, Cornelia ^a   Kipping, Marc ^b   Hecker, Michael ^a,c   Reimer, Toralf ^a   Gerber, Bernd ^a   Thiesen, Hans Jürgen ^a,c   Glocker, Michael O ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b WATERS CORPORATION   (United States)

^c IndyMed GmbH   (Germany)

Author keywords

Biomarker; Breast carcinoma; Data independent alternate scanning (LC MSE); Immunohistochemistry; Label free quantitation; Nanoscale LC MS; Protein expression signature; Proteome analysis; Therapeutic target; Western blot

Indexed keywords

BREAST CARCINOMA; BREAST CARCINOMAS; IMMUNOHISTOCHEMISTRY; LABEL FREE; NANO SCALE; PROTEIN EXPRESSIONS; PROTEOME ANALYSIS; THERAPEUTIC TARGETS; WESTERN BLOT; WESTERN BLOTS;

AMINES; FLUORINE CONTAINING POLYMERS; LABELS; NANOSTRUCTURED MATERIALS; ONTOLOGY; TUMORS;

PROTEINS;

PROTEOME; TUMOR MARKER;

AGED; ARTICLE; BIOLOGY; BREAST TUMOR; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; NANOTECHNOLOGY; PAGET NIPPLE DISEASE; PATHOLOGY; PROTEOMICS; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; NANOTECHNOLOGY; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 71449100011     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-009-3187-9     Document Type: Article

References (49)

1. CM Croce 2008 Oncogenes and cancer N Engl J Med 358 502 511 10.1056/NEJMra072367 1:CAS:528:DC%2BD1cXhtlWlur8%3D (Pubitemid 351185806)
2. AA Adjei M Hidalgo 2005 Intracellular signal transduction pathway proteins as targets for cancer therapy J Clin Oncol 23 5386 5403 10.1200/JCO.2005.23.648 1:CAS:528:DC%2BD2MXpslOrtb8%3D (Pubitemid 46206992)
3. B Gerber A Krause S Markmann T Reimer R Fietkau H Müller 2001 Effectiveness of trastuzumab (Herceptin) in a patient with locally recurrent breast cancer after cardiac failure caused by severe cytotoxic pretreatment Oncology 61 271 274 10.1159/000055333 1:STN:280:DC%2BD3MnnsFarsQ%3D%3D (Pubitemid 33135835)
4. J Baselga EA Perez T Pienkowski R Belld 2006 Adjuvant trastuzumab: a milestone in the treatment of HER-2-positive early breast cancer Oncologist 11 4 12 10.1634/theoncologist.11-90001-4 1:CAS:528:DC%2BD28XhtFKqtr7N
5. F Petrelli M Cabiddu ME Cazzaniga M Cremonesi S Barni 2008 Targeted therapies for the treatment of breast cancer in the post-trastuzumab era Oncologist 13 373 381 10.1634/theoncologist.2007-0173 1:CAS:528: DC%2BD1cXmslKksLc%3D (Pubitemid 351679916)
6. NU Lin EP Winer 2004 New targets for therapy in breast cancer: small molecule tyrosine kinase inhibitors Breast Cancer Res 6 204 210 10.1186/bcr919 1:CAS:528:DC%2BD2cXotVejtLc%3D (Pubitemid 39220375)
7. DJ Payne 2008 Microbiology. Desperately seeking new antibiotics Science 321 1644 1645 10.1126/science.1164586 1:CAS:528:DC%2BD1cXhtFOjsrbK
8. PS Steeg CE Horak KD Miller 2008 Clinical-translational approaches to the Nm23-H1 metastasis suppressor Clin Cancer Res 14 5006 5012 10.1158/1078-0432. CCR-08-0238 1:CAS:528:DC%2BD1cXpslKgsbY%3D
9. Y Kuramitsu N Kazuyuki 2006 Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers Proteomics 6 5650 5661 10.1002/pmic.200600218 1:CAS:528:DC%2BD28XhtFyms7fK (Pubitemid 44683228)
10. E Pastwa SB Somiari M Czyz RI Somiari 2007 Proteomics in human cancer research Proteomics Clin Appl 1 4 17 10.1002/prca.200600369 1:CAS:528: DC%2BD2sXjtFCjs7g%3D
11. AK Callesen W Vach PE Jørgensen S Cold O Mogensen TA Kruse ON Jensen JS Madsen 2008 Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: a systematic review J Proteome Res 7 1395 1402 10.1021/pr800115f 1:CAS:528: DC%2BD1cXisFWkt78%3D
12. H Hondermarck C Tastet I El Yazidi-Belkoura R-A Toillon X Le Bourhis 2008 Proteomics of breast cancer: the quest for markers and therapeutic targets J Proteome Res 7 1403 1411 10.1021/pr700870c 1:CAS:528:DC%2BD1cXisVylsbY%3D
13. OE Hawkins RS VanGundy AM Eckerd W Bardet R Buchli JA Weidanz WH Hildebrand 2008 Identification of breast cancer peptide epitopes presented by HLA-A*0201 J Proteome Res 7 1445 1457 10.1021/pr700761w 1:CAS:528:DC%2BD1cXjsVWhsLs%3D
14. KL Abbott K Aoki J-M Lim M Porterfield R Johnson RM O'Regan L Wells M Tiemeyer P Michael 2008 Targeted glycoproteomic identification of biomarkers for human breast carcinoma J Proteome Res 7 1470 1480 10.1021/pr700792g 1:CAS:528:DC%2BD1cXhvV2msLs%3D
15. S-T Chen T-L Pan H-F Juan T-Y Chen Y-S Lin C-M Huang 2008 Breast tumor microenvironment: proteomics highlights the treatments targeting secretome J Proteome Res 7 1379 1387 10.1021/pr700745n
16. H Lu V Goodell ML Disis 2008 Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer J Proteome Res 7 1388 1394 10.1021/pr700818f 1:CAS:528: DC%2BD1cXisVylt70%3D
17. K Ou K Yu D Kesuma M Hooi N Huang W Chen SY Lee X Pei Goh T Lk J Liu SY Soon SBA Rashid TC Putti H Jikuya T Ichikawa O Nishimura M Salto-Tellez P Tan 2008 Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping J Proteome Res 7 1518 1528 10.1021/pr700820g 1:CAS:528:DC%2BD1cXivVSkt74%3D
18. ME Sanders EC Dias BJ Xu JA Mobley D Billheimer H Roder J Grigorieva M Dowsett CL Arteaga RM Caprioli 2008 Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS J Proteome Res 7 1500 1507 10.1021/pr7008109 1:CAS:528:DC%2BD1cXktFyqt7c%3D
19. I Pucci-Minafra P Cancemi MR Marabeti NN Albanese G Di Cara P Taomina A Marrazzo 2007 Proteomic profiling of 13 paired ductal infiltrating breast carcinomas and non-tumoral adjacent counterparts Proteomics Clin Appl 1 118 129 10.1002/prca.200600334 1:CAS:528:DC%2BD2sXjtFCjsLo%3D
20. M Seike T Kondo K Fujii T Yamada A Gemma S Kudoh S Hirohashi 2004 Proteomic signature of human cancer cells Proteomics 4 2776 2788 10.1002/pmic.200300795 1:CAS:528:DC%2BD2cXns1OrsbY%3D (Pubitemid 39202177)
21. M Yamada K Fujii K Koyama S Hirohashi T Kondo 2009 The proteomic profile of pancreatic cancer cell lines corresponding to carcinogenesis and metastasis J Proteomics Bioinform 2 001 018 10.4172/jpb.1000057 1:CAS:528: DC%2BD1MXjvVSiu7s%3D
22. M Wang J You KG Bemis TJ Tegeler DPG Brown 2008 Label-free mass spectrometry-based protein quantification technologies in proteomic analysis Brief Funct Genomic Proteomic 7 329 339 10.1093/bfgp/eln031 1:CAS:528: DC%2BD1MXotFWisQ%3D%3D
23. L Alldridge G Metodieva C Greenwood K Al-Janabi L Thwaites P Sauven M Metodiev 2008 Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry J Proteome Res 7 1458 1469 10.1021/pr7007829 1:CAS:528:DC%2BD1cXhslWjtLc%3D
24. X Zhang L Li D Wei Y Yap F Chen 2007 Moving cancer diagnostics from bench to bedside Trends Biotechnol 25 166 173 10.1016/j.tibtech.2007.02.006 (Pubitemid 46420716)
25. T Kondo 2008 Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE BMB Rep 41 626 634 1:CAS:528:DC%2BD1cXht1Gls7rP
26. JC Silva R Denny CA Dorschel MV Gorenstein IJ Kass G-Z Li T McKenna MJ Nold K Richardson P Young SJ Geromanos 2005 Quantitative proteomic analysis by accurate mass retention time pairs Anal Chem 77 2187 2200 10.1021/ac048455k 1:CAS:528:DC%2BD2MXhslaitrY%3D (Pubitemid 40463836)
27. SJ Geromanos JC Silva JPC Vissers CA Dorschel G-Z Li MV Gorenstein RH Bateman JI Langridge 2009 The detection, correlation and comparison of peptide precursor and products ions from data independent LC-MS with data dependant LC-MS/MS Proteomics 9 1683 1695 10.1002/pmic.200800562 1:CAS:528: DC%2BD1MXksVKqsrc%3D
28. W Remmele HE Stegner 1987 Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue Pathologe 8 138 140 1:STN:280: DyaL2s3ovFGhsQ%3D%3D
29. T Just E Gafumbegete J Gramberg I Prüfer S Mikkat B Ringel HW Pau MO Glocker 2006 Differential proteome analysis of tonsils from children with chronic tonsillitis or with hyperplasia reveals disease-associated protein expression differences Anal Bioanal Chem 384 1134 1144 10.1007/s00216-005-0288-y 1:CAS:528:DC%2BD28XjtVegs7Y%3D (Pubitemid 43333995)
30. MM Bradford 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 248 254 10.1016/0003-2697(76)90527-3 1:CAS:528: DyaE28XksVehtrY%3D
31. P Lorenz M Bantscheff SM Ibrahim H-J Thiesen MO Glocker 2003 Proteome analysis of diseased joints from mice suffering from collagen-induced arthritis Clin Chem Lab Med 41 1622 1632 10.1515/CCLM.2003.246 1:CAS:528:DC%2BD2cXkt1yh (Pubitemid 38055013)
32. Y-Q Yu M Gilar PJ Lee ESP Bouvier JC Gebler 2003 Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins Anal Chem 75 6023 6028 10.1021/ac0346196 1:CAS:528:DC%2BD3sXnsVOitr4%3D (Pubitemid 37356487)
33. G-Z Li JPC Vissers JC Silva D Golick MV Gorenstein SJ Geromanos 2009 Database searching and accounting of data independent acquired precursor and products ions from simple and complex peptide mixtures Proteomics 9 1696 1719 10.1002/pmic.200800564 1:CAS:528:DC%2BD1MXksVKqs74%3D
34. JPC Vissers JI Langridge JMFG Aerts 2007 Analysis and quantification of diagnostic serum markers and protein signatures for gaucher disease Mol Cell Proteomics 6 755 766 10.1074/mcp.M600303-MCP200 1:CAS:528:DC%2BD2sXlsV2ktL8%3D (Pubitemid 46831929)
35. Jollife JT (1986) Principal component analysis. Springer, New York
36. Schölkopf B, Smola AJ (2002) Learning with kernels. MIT Press, Cambridge, MA
37. Cawley GC (2000) School of information systems. University of East Anglia, Norwich, Norfolk, UK
38. Tukey JW (1977) Exploratory data analysis. Addison Wesley, UK
39. CW Elston 2005 Classification and grading of invasive breast carcinoma Verh Dtsch Ges Pathol 89 35 44 1:STN:280:DC%2BD2snpvFGqug%3D%3D
40. -/- embryonic stem cells by means of accurate mass LC-MS analysis J Proteome Res 8 1047 1058 10.1021/pr800485c 1:CAS:528:DC%2BD1MXmvVWnsw%3D%3D
41. E-A virtue of parallel MS acquisition Mol Cell Proteomics 5 144 156 1:CAS:528:DC%2BD28Xms1aruw%3D%3D
42. M Ashburner CA Ball JA Blake D Botstein H Butler JM Cherry AP Davis K Dolinski SS Dwight JT Eppig MA Harris DP Hill L Issel-Tarver A Kasarskis S Lewis JC Matese JE Richardson M Ringwald GM Rubin G Sherlock 2000 Gene ontology: tool for the unification of biology Nat Genet 25 25 29 10.1038/75556 1:CAS:528:DC%2BD3cXjtFSlsbc%3D (Pubitemid 30257031)
43. DR Ciocca SK Calderwood 2005 Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications Cell Stress Chaperones 10 86 103 10.1379/CSC-99r.1 1:CAS:528:DC%2BD2MXmsFymur4%3D (Pubitemid 40942470)
44. DR Ciocca P Frayssinet FD Cuello-Carrión 2007 A pilot study with a therapeutic vaccine based on hydroxyapatite ceramic particles and self-antigens in cancer patients Cell Stress Chaperones 12 33 43 10.1379/CSC-218R.1 1:CAS:528:DC%2BD2sXkslyntbw%3D (Pubitemid 47403326)
45. M Shadidi D Sørensen A Dybwad G Furset M Sioud 2008 Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma Int J Oncol 32 241 247 1:CAS:528:DC%2BD1cXhtVOlu7k%3D
46. J Petrak R Ivanek O Toman R Cmejla J Cmejlova D Vyoral J Zivny CD Vulpe 2008 Déjà vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins Proteomics 8 1744 1749 10.1002/pmic.200700919 1:CAS:528:DC%2BD1cXlvFelt7k%3D (Pubitemid 351678270)
47. P Wang FG Bouwman ECM Mariman 2009 Generally detected proteins in comparative proteomics-a matter of cellular stress response? Proteomics 9 2955 2966 10.1002/pmic.200800826 1:CAS:528:DC%2BD1MXntlGgtbg%3D
48. M Bantscheff M Schirle G Sweetman J Rick B Kuster 2007 Quantitative mass spectrometry in proteomics: a critical review Anal Bioanal Chem 389 1017 1031 10.1007/s00216-007-1486-6 1:CAS:528:DC%2BD2sXhtVyntbfF (Pubitemid 47482251)
49. MO Glocker R Guthke J Kekow H-J Thiesen 2006 Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine Med Res Rev 26 63 87 10.1002/med.20045 1:CAS:528:DC%2BD28Xmt1CitA%3D%3D (Pubitemid 43986470)